BioCentury
ARTICLE | Clinical News

SomatoKine IGF-1/BP3 complex regulatory update

April 10, 2000 7:00 AM UTC

CTRX received U.S. Patent No. 6,040,292 covering the use of SomatoKine to treat Type I and Type II diabetes. ...